Lupus Erythematosus, Systemic

Immunology·MeSH: Lupus Erythematosus, Systemic

Prevalence

30.0 / 100K

9 drugs in development·8 companies·13 clinical trials

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
AZD0120	ASTRAZENECA PLC (AZN)
cenerimod	Innovation Pharmaceuticals Inc. (IPIX)
Cenerimod	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 2(3)

Phase 1(2)

Drug	Company
AZD0120	Merus N.V. (MRUS)
cenerimod	Viatris Inc (VTRS)

Phase 1/Phase 2(1)

Drug	Company
Fludarabine	ASTRAZENECA PLC (AZN)

BioSniper tracks 9 drugs in development for Lupus Erythematosus, Systemic across 8 companies.

There are 13 clinical trials targeting Lupus Erythematosus, Systemic tracked by BioSniper.

The estimated prevalence of Lupus Erythematosus, Systemic is approximately 30.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.